US2020205976A1PendingUtilityA1
Delivery device for medical implant and medical procedure
Est. expiryAug 3, 2031(~5.1 yrs left)· nominal 20-yr term from priority
Inventors:Anders Jonsson
A61F 2250/0096A61B 34/10A61F 2/2445A61F 2/2466A61B 2034/104A61F 2220/0008A61B 2034/108
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A catheter based medical system and medical procedure for reducing cardiac valve regurgitation are disclosed. The system comprises a resilient curvilinear shaped annuloplasty implant for reducing the size of a dilated annulus of said valve for reducing said regurgitation having resilient anchoring elements, and a delivery device for said annuloplasty implant having a distal curvilinear shaped portion that is hollow to mount said annuloplasty implant and has an annular opening arranged to be in apposition against an annulus of said cardiac valve. A plurality of suction units allows for a atrial approach and symmetric implantation of said implant.
Claims
exact text as granted — not AI-modifiedThat which is claimed:
1 . A catheter based medical system, including a retractable delivery device for delivery of a medical implant, such as an annuloplasty implant for reducing cardiac valve regurgitation, having a distal portion for releasably holding said implant, and for apposition against a target tissue for said implant, such as an annulus of a cardiac valve, wherein said distal portion comprises a plurality of suction units for providing and/or determining a desired apposition of said distal portion at said target tissue prior to releasing said medical implant to said tissue and retracting said delivery device.
2 . The system of claim 1 , wherein said suction units are provideable with a negative pressure for suction to said tissue, and wherein said medical implant is not releasable before all suction units are confirmed in apposition with said tissue.
3 . The system of claim 1 , wherein said plurality of suction units are distributed along a periphery of said distal portion.
4 . The system of claim 1 , wherein a firm seat at said tissue is confirmed by an absence of a reflow of blood from said suction units.
5 . The system of claim 1 , wherein said suction units are arranged to provide for a symmetric delivery of said implant when release to said tissue.
6 . The system of claim 1 , wherein said tissue is a cardiac valve annulus and said implant is an annuloplasty implant, such that said distal portion is arrangeable for a synchronous and simultaneous reshaping procedure of said annulus by said implant.
7 . The system of claim 1 , wherein apposition of said suction units is measurable based on a signal for a pressure in said suction unit an energy consumption of a flow generator generating said pressure.
8 . The system of claim 1 , wherein said distal portion has arranged thereon a plurality of sensors for indicating contact with said annulus tissue, such as piezo transducers.
9 . The system of claim 1 , wherein said cardiac valve is a mitral valve, and wherein said system is adapted for transseptal percutaneous delivery into the left atrium to said atrial side of said mitral valve, and wherein a delivery portion of said delivery device is distally connected to said distal portion and has a distal curvature to allow access from a septal opening towards said mitral valve.
10 . The system of claim 1 , wherein said cardiac valve is a tricuspid valve, and wherein said system is adapted for percutaneous delivery into the right atrium to said atrial side of said tricuspid valve, and wherein a delivery portion of said delivery device is distally connected to said distal portion and has a distal curvature to allow suitable access towards said tricuspid valve.
11 . The system of claim 1 , wherein said implant is a resilient curvilinear shaped annuloplasty implant that has a tissue engaging conformation based on a desired downsized shape where said regurgitation of said valve is reduced, and said distal portion has a delivery conformation based on a shape of said dilated valve annulus shape, wherein said delivery conformation has a dimension that is larger than said tissue engaging conformation of said annuloplasty implant, such that said annuloplasty implant is resiliently kept in said delivery conformation before release from said distal portion.
12 . The system of claim 1 , wherein said distal portion has at least one fiducial marker, wherein said fiducial marker is preferably arranged at a periphery of said distal portion;
and/or wherein one of said fiducial markers is an annular fiducial marker arranged along said periphery; and/or having a plurality of fiducial markers distributed along said distal curvilinear shaped portion for identifying said distal curvilinear shaped portion inside a body of a patient having said cardiac valve.
13 . The system of claim 12 , wherein said fiducial markers include an air inclusion for detection by ultrasound.
14 . A medical procedure for reducing cardiac valve regurgitation including the steps of:
measuring the geometry of a dilated cardiac valve of a patient including the shape and size of a dilated annulus thereof; determining the downsized shape and size of said annulus; selecting a resilient annuloplasty implant having in a tissue engaging conformation a shape and size to be arranged at said downsized annulus based on said determined downsized shape and size of said annulus; introducing said annuloplasty implant in a delivery device in a compressed state via a catheter to said cardiac valve; releasing an aggregate of a distal portion of said delivery device and said annuloplasty implant in a stretched state in said delivery device from said catheter such that implant assumes an expanded shape; positioning said aggregate at said annulus; fixation said distal portion to said annulus, e.g. by activating suction of suction units; providing and/or verifying a desired apposition of said distal portion at said annulus prior to releasing said implant; releasing and anchoring said annuloplasty implant into said annulus; reducing the size of said delivery device and/or annuloplasty implant for reshaping said annulus to said downsized shape; optionally determining a reduction of said cardiac valve regurgitation, and removing said delivery device and catheter if the reduction is satisfactory, or removing said annuloplasty implant together with said delivery device when said reduction is determined as not being satisfactory.
15 . The procedure of claim 14 , including ultrasonic measurement for said measuring the geometry of said dilated cardiac valve, and/or said determining a reduction of said cardiac valve regurgitation.
16 . The procedure of claim 14 , including:
applying a catheter based medical system for reducing said cardiac valve regurgitation, having said resilient curvilinear shaped annuloplasty implant for reducing the size of a dilated annulus of said valve for reducing said regurgitation, and a delivery device for said annuloplasty implant having a distal portion receiving said annuloplasty implant and has an opening arranged to be in apposition against an annulus of said cardiac valve; said procedure including releasably mounting said annuloplasty implant in said hollow with said resilient anchoring elements arranged in a restrained spring loaded delivery conformation in said hollow, for said introducing; positioning said aggregate at said annulus; fixation said distal portion to said annulus, e.g. by activating suction of suction units; providing and/or verifying a desired apposition of said distal portion at said annulus prior to releasing said implant; releasing and anchoring said annuloplasty implant into said annulus.
17 . The procedure of claim 14 , including restraining said annuloplasty implant in said hollow of said distal portion with a second restraining unit, and releasing said annuloplasty implant from said hollow upon releasing said second restraining unit, wherein said second restraining unit preferably is only released when a correct position of said annuloplasty implant is confirmed, allowing for removing said annuloplasty implant from said annulus if the correct positioning of said annuloplasty implant is not confirmed, and avoiding undesired embolization of said annuloplasty implant.
18 . The procedure of claim 14 , including making a transseptal puncture in said heart; wherein said cardiac valve is a mitral valve, and wherein said introducing is a transseptal percutaneous delivery into the left atrium to said atrial side of said mitral valve, and wherein a delivery portion of said delivery device is distally connected to said distal curvilinear shaped portion and has a distal curvature to allow access from a septal opening towards said mitral valve.
19 . The procedure of claim 14 , including making a transseptal puncture in said heart; wherein said cardiac valve is tricuspid valve, and wherein said system is adapted for percutaneous delivery into the right atrium to said atrial side of said tricuspid valve, and wherein a delivery portion of said delivery device is distally connected to said distal curvilinear shaped portion and has a distal curvature to allow suitable access towards said tricuspid valve.
20 . The procedure of claim 14 , including generating a negative pressure in suction units of said distal portion for suction of said distal portion to said annulus.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.